Oct. 8, 2020 Patent granted for enhancement of adipose-derived mesenchymal stem cells by statin PLGA nanoparticles for inflammatory diseases in Japan

An agent reported on October 7, 2020 that a patent to enhance the function of adipose-derived stem cells by adding statin PLGA nanoparticles was evaluated and was granted in Japan.

This makes it easy for us to develop our business in Japan using our technology.